The peptide industry is about to change more in 12 months than it has in the last decade. Here’s what FDA reclassification means for quality, access, pricing, and the people who’ve been in this space all along.
14 of 19 restricted peptides are being reclassified in 2026. Here’s every peptide on the list, what each one is known for, the confirmed FDA timeline, and what Category 1 status actually means.
RFK Jr announced 14 peptides moving out of Category 2 on Joe Rogan. The FDA advisory committee is now confirmed for July 2026. Here’s the full timeline, every peptide on the list, and what reclassification actually means.
Peptide Sciences ceased operations in March 2026, shutting down its website and stopping all orders. The closure followed increased FDA enforcement against peptide suppliers.
Yes, peptides are legal to purchase for research purposes in the United States in 2026. They are sold as research chemicals and are not classified as controlled substances.
BPC-157 is legal to purchase for research purposes in the United States. It is not FDA-approved for human use and is sold as a research chemical.
The End of an Era: Peptide Sciences Closes Its Doors On March 6, 2026, at approximately 2:00 PM Eastern, one of the longest-running names in the grey-market research peptide industry went dark. Peptide Sciences — a U.S.
When RFK Jr. went on Joe Rogan and named 14 peptides he wanted removed from Category 2 restrictions, the research community took notice. Here’s the full list, what Category 2 actually means, and what could change.
A comprehensive guide to peptide legality in 2026 — covering the FDA’s stance, research-use framework, Category 2 restrictions, the SAFE Act, RFK Jr.’s reclassification announcement, and state-level variation.
What Is GDF-8 (Myostatin)? Growth Differentiation Factor 8 (GDF-8), more commonly known as myostatin, is a secreted protein belonging to the transforming growth factor beta (TGF-β) superfamily.
